Clark M R, Liu L, Clarkson S B, Ory P A, Goldstein I M
Rosalind Russell Arthritis Research Laboratory, Department of Medicine, University of California, San Francisco 94143.
J Clin Invest. 1990 Jul;86(1):341-6. doi: 10.1172/JCI114706.
In the course of examining the structure and function of Fc receptors on peripheral blood cells of patients with systemic lupus erythematosus, we identified a patient whose neutrophils did not react with either monoclonal or polyclonal antibodies to Fc receptor III. However, neutrophils from the patient were comparable to neutrophils from healthy controls with respect to their expression of Fc receptor II, complement receptor 1, complement receptor 3, and the phosphatidylinositol-linked, complement regulatory protein, decay-accelerating factor. The abnormality of expression of Fc receptor III was limited to the patient's neutrophils (her natural killer cells reacted normally with anti-Fc receptor III antibodies), and was associated with abnormal recognition and binding of IgG-coated erythrocytes. Analysis of genomic DNA revealed evidence that failure of the patient's neutrophils to express Fc receptor III was most likely due to an abnormality of the gene that encodes this receptor.
在研究系统性红斑狼疮患者外周血细胞上Fc受体的结构和功能过程中,我们发现一名患者,其嗜中性粒细胞与针对Fc受体III的单克隆或多克隆抗体均无反应。然而,该患者的嗜中性粒细胞在Fc受体II、补体受体1、补体受体3以及磷脂酰肌醇连接的补体调节蛋白衰变加速因子的表达方面,与健康对照者的嗜中性粒细胞相当。Fc受体III表达异常仅限于该患者的嗜中性粒细胞(她的自然杀伤细胞与抗Fc受体III抗体反应正常),并且与IgG包被红细胞的异常识别和结合有关。基因组DNA分析显示,该患者嗜中性粒细胞未能表达Fc受体III很可能是由于编码此受体的基因异常所致。